[{"ref-id":"L6151","title":"Depacon FDA Label (2006)","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/018081s42,18082s26,18723s32,19680s19,20593s11,21168s9lbl.pdf","parent_key":"DB00313"},{"ref-id":"L6190","title":"Depakene FDA","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=018081","parent_key":"DB00313"},{"ref-id":"L6196","title":"Depakene FDA Label (2019)","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/018081s069,018082s052lbl.pdf","parent_key":"DB00313"},{"ref-id":"L12978","title":"FDA Approved Drug Products: ZOMIG\/ZOMIG-ZMT (zolmitriptan) oral tablets and nasal spray","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020768s023,021231s014,021450s010lbl.pdf","parent_key":"DB00315"},{"ref-id":"L5756","title":"Acetaminophen tablet, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c3b408ff-f47b-4fee-ade5-5db6e25f4ee0","parent_key":"DB00316"},{"ref-id":"L5774","title":"Acetaminophen effervescent tablets, Cleveland Clinic","url":"https:\/\/my.clevelandclinic.org\/health\/drugs\/18282-acetaminophen-effervescent-tablets","parent_key":"DB00316"},{"ref-id":"L5777","title":"FDA safety communication: FDA has reviewed possible risks of pain medicine use during pregnancy","url":"https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm429117.htm","parent_key":"DB00316"},{"ref-id":"L5780","title":"U.S. National Medical Library: MedlinePlus- Acetaminophen dosing for children","url":"https:\/\/medlineplus.gov\/ency\/patientinstructions\/000783.htm","parent_key":"DB00316"},{"ref-id":"L5783","title":"FDA consumer health information: Acetaminophen","url":"https:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm263989.htm","parent_key":"DB00316"},{"ref-id":"L5786","title":"FDA : Acetaminophen Information","url":"https:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm165107.htm","parent_key":"DB00316"},{"ref-id":"L5789","title":"Using Acetaminophen and Nonsteroidal Anti-inflammatory Drugs Safely","url":"https:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/BuyingUsingMedicineSafely\/UnderstandingOver-the-CounterMedicines\/SafeUseofOver-the-CounterPainRelieversandFeverReducers\/ucm164977.htm","parent_key":"DB00316"},{"ref-id":"L4396","title":"Acetaminophen FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/204767s000lbl.pdf","parent_key":"DB00316"},{"ref-id":"L5506","title":"Codeine phosphate tablets, 30mg","url":"https:\/\/www.medicines.org.uk\/emc\/product\/5753\/smpc","parent_key":"DB00318"},{"ref-id":"L5521","title":"DailyMed: Codeine and promethazine syrup","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a5215931-3385-4d8e-b121-47aa1c20420c&audience=consumer","parent_key":"DB00318"},{"ref-id":"L5524","title":"Codittusin, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=99f53fa4-98e0-4f0c-9bb2-4c7163f841ec","parent_key":"DB00318"},{"ref-id":"L5308","title":"Amitriptyline FDA information, Approval","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=085971","parent_key":"DB00321"},{"ref-id":"L5795","title":"FDA approvals","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=019034","parent_key":"DB00327"},{"ref-id":"L5798","title":"Clinical trials","url":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01123486","parent_key":"DB00327"},{"ref-id":"L6778","title":"Indomethacin Capsules (25 mg) - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/016059s100lbl.pdf","parent_key":"DB00328"},{"ref-id":"L10553","title":"Indocin I.V. (indomethacin for injection) - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/018878s027lbl.pdf","parent_key":"DB00328"},{"ref-id":"L13269","title":"FDA Approved Drug Products: INDOCIN (indomethacin) Suppositories, for rectal use","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/017814s041s042lbl.pdf","parent_key":"DB00328"},{"ref-id":"L4087","title":"Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program","url":"https:\/\/www.bmj.com\/content\/350\/bmj.h454\/rr-0","parent_key":"DB00331"},{"ref-id":"L5753","title":"UptoDate: Pathogenesis of type 2 diabetes mellitus","url":"https:\/\/www.uptodate.com\/contents\/pathogenesis-of-type-2-diabetes-mellitus","parent_key":"DB00331"},{"ref-id":"L11479","title":"FDA Approved Drug Products: Trijardy XR (empagliflozin\/linagliptin\/metformin) extended-release tablets","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/212614s000lbl.pdf","parent_key":"DB00331"},{"ref-id":"L12207","title":"FDA approved products: Glumetza (metformin) oral tablets","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021748s010lbl.pdf","parent_key":"DB00331"},{"ref-id":"L5891","title":"FDA approvals","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=019085","parent_key":"DB00332"},{"ref-id":"L5894","title":"FDA approvals","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=020291","parent_key":"DB00332"},{"ref-id":"L5900","title":"Journal of Investigational Allergology and Clinical Immunology","url":"http:\/\/www.jiaci.org\/issues\/vol20s1\/7.pdf","parent_key":"DB00332"},{"ref-id":"L5903","title":"The differential diagnosis of rhinorrhea","url":"https:\/\/www.jacionline.org\/article\/S0091-6749(95)70211-3\/pdf","parent_key":"DB00332"},{"ref-id":"L5906","title":"COPD Foundation","url":"https:\/\/www.copdfoundation.org\/What-is-COPD\/Understanding-COPD\/What-is-COPD.aspx","parent_key":"DB00332"},{"ref-id":"L5909","title":"EMC","url":"https:\/\/www.medicines.org.uk\/emc\/product\/3213\/smpc","parent_key":"DB00332"},{"ref-id":"L5936","title":"Canadian Mental Health Association","url":"https:\/\/cmha.ca\/mental-health\/understanding-mental-illness\/schizophrenia","parent_key":"DB00334"},{"ref-id":"L5939","title":"NIH","url":"https:\/\/www.nimh.nih.gov\/health\/topics\/bipolar-disorder\/index.shtml","parent_key":"DB00334"},{"ref-id":"L5945","title":"Mylan-Olanzapine. Product monograph","url":"https:\/\/pdf.hres.ca\/dpd_pm\/00038283.PDF","parent_key":"DB00334"},{"ref-id":"L12591","title":"FDA Approved Drug Products: Zyprexa (olanzapine)","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020592s072,021086s047,021253s060lbl.pdf","parent_key":"DB00334"},{"ref-id":"L13059","title":"FDA Approved Drug Products: Zyprexa (olanzapine) tablets and powder","url":"https:\/\/pi.lilly.com\/us\/zyprexa-pi.pdf","parent_key":"DB00334"},{"ref-id":"L6313","title":"LactMed: Atenolol","url":"http:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/search2\/r?dbs+lactmed:@term+@DOCNO+283","parent_key":"DB00335"},{"ref-id":"L6316","title":"ChemIDplus: Atenolol","url":"https:\/\/chem.nlm.nih.gov\/chemidplus\/rn\/29122-68-7","parent_key":"DB00335"},{"ref-id":"L12804","title":"FDA Approved Products: Tenormin (atenolol) oral tablets","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/018240s032lbl.pdf","parent_key":"DB00335"},{"ref-id":"L9743","title":"FDA Approved Drug Products: Talicia Amoxicillin, Omeprazole, and Rifabutin Oral Delayed Release Capsules","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/213004lbl.pdf","parent_key":"DB00338"},{"ref-id":"L12309","title":"NIH StatPearls: Omeprazole","url":"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539786\/","parent_key":"DB00338"},{"ref-id":"L12933","title":"FDA Approved Products: Prilosec (omeprazole) delayed release capsules","url":"https:\/\/s3-us-west-2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/003\/712\/original\/Prilosec_FDA.pdf?1551285648","parent_key":"DB00338"},{"ref-id":"L5","title":"Link","url":"http:\/\/newdruginformation.com\/Trest.htm","parent_key":"DB00340"},{"ref-id":"L6289","title":"Diltiazem - StatPearls - NCBI Bookshelf","url":"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532937\/","parent_key":"DB00343"},{"ref-id":"L6292","title":"Diltiazem Hydrochloride Injection Label - Bedford Laboratories","url":"https:\/\/docs.boehringer-ingelheim.com\/Prescribing%20Information\/PIs\/Ben%20Venue_Bedford%20Labs\/55390-565-10%20DLT%2050MG\/5539056510","parent_key":"DB00343"},{"ref-id":"L6298","title":"Cardizem (diltiazem hydrochloride) Drug Summary - PDR.net","url":"https:\/\/www.pdr.net\/drug-summary\/Cardizem-diltiazem-hydrochloride-2077","parent_key":"DB00343"},{"ref-id":"L10556","title":"CARDIZEM\u00ae LA (diltiazem hydrochloride) extended-release tablets - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021392s019lbl.pdf","parent_key":"DB00343"},{"ref-id":"L10559","title":"CARDIZEM\u00ae CD (diltiazem HCl) Capsules - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020062s040lbl.pdf","parent_key":"DB00343"},{"ref-id":"L9251","title":"FDA Approved Drug Products: Alfuzosin Extended Release Tablets","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021287s021lbl.pdf","parent_key":"DB00346"},{"ref-id":"L6217","title":"FDA approval: Buclizine","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=010911","parent_key":"DB00354"},{"ref-id":"L6220","title":"HMDB: Buclizine","url":"http:\/\/www.hmdb.ca\/metabolites\/HMDB0014498","parent_key":"DB00354"},{"ref-id":"L1998","title":"Vinorelbine Tartrate","url":"https:\/\/www.pfizer.ca\/sites\/g\/files\/g10037206\/f\/201710\/VINORELBINE_TARTRATE_FOR_INJECTION_PM.pdf","parent_key":"DB00361"},{"ref-id":"L2000","title":"Vinorelbine, Ontario Cancer Care","url":"https:\/\/www.cancercareontario.ca\/en\/system\/...\/vinorelbine.pdf","parent_key":"DB00361"},{"ref-id":"L2002","title":"Predictors of Vinorelbine Pharmacokinetics and Pharmacodynamics in Patients With Cancer","url":"http:\/\/ascopubs.org\/doi\/abs\/10.1200\/jco.2005.02.1295","parent_key":"DB00361"},{"ref-id":"L2004","title":"Vinorelbine injection, Daily Med","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=06eeaab8-a00d-4b41-b46b-40163f09ecb8","parent_key":"DB00361"},{"ref-id":"L2005","title":"Metabolism pathway of vinorelbine (Navelbine\u00ae) in human: Characterisation of the metabolites by HPLC\u2013MS\/MS","url":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0731708507007625","parent_key":"DB00361"},{"ref-id":"L2006","title":"Vinca Alkaloid Pharmacokinetics","url":"https:\/\/www.pharmgkb.org\/pathway\/PA150981002","parent_key":"DB00361"},{"ref-id":"L2007","title":"Vinorelbine, a clinical review","url":"https:\/\/www.nature.com\/articles\/6691203.pdf?origin=ppub","parent_key":"DB00361"},{"ref-id":"L2009","title":"Vinorelbine FDA pharmacology review","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2000\/20-388S008_Navelbine_biopharmr.pdf","parent_key":"DB00361"},{"ref-id":"L2010","title":"Drug Approval Package","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2000\/20-388s008_Navelbine.cfm","parent_key":"DB00361"},{"ref-id":"L2011","title":"Navelbine, PDR","url":"http:\/\/www.pdr.net\/drug-summary\/Navelbine-vinorelbine-tartrate-2360","parent_key":"DB00361"},{"ref-id":"L6073","title":"FDA approval, Sucralfate suspension","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=019183","parent_key":"DB00364"},{"ref-id":"L6076","title":"Sucralfate tablet FDA approval","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=018333","parent_key":"DB00364"},{"ref-id":"L7760","title":"Levonorgestrel FDA label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021998lbl.pdf","parent_key":"DB00367"},{"ref-id":"L7766","title":"Alesse 28 FDA label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020683s012lbl.pdf","parent_key":"DB00367"},{"ref-id":"L7778","title":"FDA label, Mirena IUD","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021225s019lbl.pdf","parent_key":"DB00367"},{"ref-id":"L7781","title":"Kyleena IUD FDA label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208224s000lbl.pdf","parent_key":"DB00367"},{"ref-id":"L7787","title":"Jaydess monograph","url":"https:\/\/www.bayer.ca\/omr\/online\/jaydess-pm-pt3-en.pdf","parent_key":"DB00367"},{"ref-id":"L7790","title":"Levonorgestrel MSDS","url":"http:\/\/datasheets.scbt.com\/sc-205731.pdf","parent_key":"DB00367"},{"ref-id":"L7793","title":"Medicines UK, levonorgestrel","url":"https:\/\/www.medicines.org.uk\/emc\/product\/7308\/smpc","parent_key":"DB00367"},{"ref-id":"L7796","title":"Birth control pill overdose, Medline","url":"https:\/\/medlineplus.gov\/ency\/article\/002599.htm","parent_key":"DB00367"},{"ref-id":"L7805","title":"Climara pro FDA label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/021885lbl.pdf","parent_key":"DB00367"},{"ref-id":"L7808","title":"Cleveland clinic: hormone therapy","url":"https:\/\/my.clevelandclinic.org\/health\/treatments\/15245-hormone-therapy","parent_key":"DB00367"},{"ref-id":"L7823","title":"Norplant FDA label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020544s010lbl.pdf","parent_key":"DB00367"},{"ref-id":"L6223","title":"Cidofovir FDA approval","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=020638","parent_key":"DB00369"},{"ref-id":"L6139","title":"Bioavailability of mirtazapine from Remeron\u00ae tablets after single and multiple oral dosing","url":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.470100803","parent_key":"DB00370"},{"ref-id":"L6157","title":"Remeron approval, 1997","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/97\/20-415S003_Remeron_Prntlbl.pdf","parent_key":"DB00370"},{"ref-id":"L6160","title":"Mirtazapine: A Newer Antidepressant, American Family Physician (AFP)","url":"https:\/\/www.aafp.org\/afp\/1999\/0101\/p159.html","parent_key":"DB00370"},{"ref-id":"L4433","title":"Remeron (Mirtazapine) FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020415s023s024.pdf","parent_key":"DB00370"},{"ref-id":"L6724","title":"Timolol FDA Label (Ophthalmic)","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021516s005lbl.pdf","parent_key":"DB00373"},{"ref-id":"L6727","title":"Timolol maleate tablet","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=57c62928-63d8-4505-9b9e-c085a3a12c95","parent_key":"DB00373"},{"ref-id":"L6730","title":"Monograph, GD-LATANOPROST\/TIMOLOL","url":"https:\/\/www.pfizer.ca\/sites\/g\/files\/g10050796\/f\/201710\/GD-latanoprost_and_timolol_PM_E_210086_17Oct2017.pdf","parent_key":"DB00373"},{"ref-id":"L6733","title":"CV Pharmacology","url":"https:\/\/www.cvpharmacology.com\/cardioinhibitory\/beta-blockers","parent_key":"DB00373"},{"ref-id":"L6736","title":"Approval information, FDA","url":"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=207556","parent_key":"DB00373"},{"ref-id":"L6742","title":"FDA summary review","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/761077Orig1s000SumR.pdf","parent_key":"DB00373"},{"ref-id":"L6","title":"Link","url":"http:\/\/www.inchem.org\/documents\/pims\/pharm\/timolol.htm","parent_key":"DB00373"},{"ref-id":"L6757","title":"MedSafe NZ, Timolol","url":"https:\/\/medsafe.govt.nz\/Profs\/Datasheet\/a\/ArrowTimololeyedrops.pdf","parent_key":"DB00373"},{"ref-id":"L6115","title":"Electronic Medicines Compendium: Colestid (colestipol hydrochloride) Orange 5g Monograph","url":"https:\/\/www.medicines.org.uk\/emc\/product\/129\/smpc","parent_key":"DB00375"},{"ref-id":"L6118","title":"NCBI LactMed@NIH Drugs and Lactation Database (LactMed) [Internet]: Colestipol Profile","url":"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501393\/#LM514.admin-info","parent_key":"DB00375"},{"ref-id":"L6262","title":"Colestipol ScienceDirect Profile","url":"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/colestipol","parent_key":"DB00375"},{"ref-id":"L7598","title":"Colestid\u00ae (colestipol hydrochloride for oral suspension) - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/017563s023,020222s005lbl.pdf","parent_key":"DB00375"},{"ref-id":"L104","title":"Link","url":"http:\/\/www.patient.co.uk\/showdoc\/30003042\/","parent_key":"DB00378"},{"ref-id":"L9314","title":"FDA Approved Drug Products: Amlodipine Oral Tablets","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/019787s062lbl.pdf","parent_key":"DB00381"},{"ref-id":"L9317","title":"FDA Approved Drug Products: Amlodipine Oral Suspension","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211340s000lbl.pdf","parent_key":"DB00381"},{"ref-id":"L6163","title":"Triamterene - International Agency for Research on Cancer (IARC) Monographs","url":"https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono108-10.pdf","parent_key":"DB00384"},{"ref-id":"L6169","title":"DYAZIDE (hydrochlorothiazide and triamterene) - FDA Label","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/016042s077lbl.pdf","parent_key":"DB00384"},{"ref-id":"L6193","title":"PRO-TRIAZIDE (Triamterene 50 mg and Hydrochlorothiazide 25 mg) - Product Monograph","url":"https:\/\/pdf.hres.ca\/dpd_pm\/00026038.PDF","parent_key":"DB00384"},{"ref-id":"L6166","title":"DailyMed - DYRENIUM- triamterene capsule","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af","parent_key":"DB00384"},{"ref-id":"L9416","title":"FDA Approved Drug Products: Phenylephrine Solution for Intravenous Injection","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/204300lbl.pdf","parent_key":"DB00388"},{"ref-id":"L9413","title":"FDA Approved Drug Products: Phenylephrine Ophthalmic Solution","url":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/207926s002lbl.pdf","parent_key":"DB00388"}]